{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:04:13Z","timestamp":1648652653872},"reference-count":7,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.parkreldis.2013.12.013","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T01:15:35Z","timestamp":1389143735000},"page":"665-667","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA"],"prefix":"10.1016","volume":"20","author":[{"given":"Lucia","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Ialongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Guidubaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Di Giacopo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Bentivoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.parkreldis.2013.12.013_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"issue":"Suppl. 2","key":"10.1016\/j.parkreldis.2013.12.013_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2009.02880.x","article-title":"Clinical efficacy and tolerability of Xeomin\u00ae in the treatment of blepharospasm","volume":"16","author":"Jankovic","year":"2009","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2013.12.013_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp.60.6.693-a","article-title":"Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients","volume":"60","author":"Albanese","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.parkreldis.2013.12.013_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1442-9071.2006.01236.x","article-title":"Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?","volume":"34","author":"Ferreira","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.parkreldis.2013.12.013_bib5","first-page":"225","article-title":"Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia","volume":"27","author":"Ferreira","year":"2012","journal-title":"Funct Neurol"},{"issue":"9","key":"10.1016\/j.parkreldis.2013.12.013_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2340\/16501977-1009","article-title":"Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report","volume":"44","author":"Santamato","year":"2012","journal-title":"J Rehabil Med"},{"issue":"3","key":"10.1016\/j.parkreldis.2013.12.013_bib7","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/ene.12076","article-title":"Xeomin\u00ae use in patients with systemic immune reactions to other botulinum toxins type A","volume":"20","author":"Ricciardi","year":"2013","journal-title":"Eur J Neurol"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013004501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013004501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T11:25:01Z","timestamp":1538911501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013004501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1353802013004501"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.12.013","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}